Filing Details
- Accession Number:
- 0001104659-15-049648
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-02 17:06:42
- Reporting Period:
- 2015-07-01
- Filing Date:
- 2015-07-02
- Accepted Time:
- 2015-07-02 17:06:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Ophthotech Corp. | OPHT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1220051 | A Barbara Wood | C/O Ophthotech Corporation One Penn Plaza, 19Th Floor New York NY 10119 | Svp,General Counsel, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-01 | 2,000 | $24.49 | 2,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-07-01 | 2,000 | $51.94 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-07-01 | 2,000 | $0.00 | 2,000 | $24.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 64,000 | 2023-11-17 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2013.
- These shares were disposed of in multiple transactions on July 1, 2015 at actual sales prices ranging from $51.66 to $52.23 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option was granted on November 18, 2013 and will vest over a four-year period, with 17,500 shares underlying such option vesting in November 2014 and 1/48 of the original number of shares underlying such option vesting each month thereafter until November 2017.
Billionaire Hedge Funds
